Human embryonic stem cell therapy for aplastic anemia
Human embryonic stem cell (hESC) therapy is the potential therapeutic option for the treatment of patients with aplastic anemia (AA)
A review of the emerging potential therapy for neurological disorders: human embryonic stem cell therapy
The first human embryonic stem cell (hESC) line was developed in the late nineties. hESCs are capable of proliferating indefinitely and differentiate into all the three embryonic germ layers.